Compare Globus Medical Inc. Class A Common Stock (GMED) vs Roundhill NVDA WeeklyPay ETF (NVDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Roundhill NVDA WeeklyPay ETF — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Roundhill NVDA WeeklyPay ETF trades at $34.64 (market cap $116.11M). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 88.3× Roundhill NVDA WeeklyPay ETF's market cap, and Globus Medical Inc. Class A Common Stock is trading nearer its 52-week high, Roundhill NVDA WeeklyPay ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Roundhill NVDA WeeklyPay ETF for 52 Days on average.
| GMED | NVDW | |
|---|---|---|
Market Cap | $10.25B | $116.11M |
Volume | 1,108,124 | 41,612 |
Sector | Health | Income / Options Overlay |
52-Week High | $96.82 | $52.33 |
52-Week Low | $58.33 | $31.88 |
Typical Hold Time | 0 Days | 52 Days |
Enterprise Value | $9.76B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
NVDW trades at $36.64 with minimal daily movement (+0.14%). Technical indicators show a bearish trend with strong sell signals from moving averages, though RSI suggests potential oversold conditions. The ETF generates weekly dividend income from Nvidia exposure but carries leverage risks. Recent news highlights its high-yield potential amid Nvidia's strong earnings performance.
The outlook remains cautious due to leveraged structure and dependency on Nvidia volatility. While weekly dividends offer income appeal, NAV erosion during Nvidia downturns presents significant risk. Investors should weigh high yield potential against elevated volatility exposure in this specialized income vehicle.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Roundhill NVDA WeeklyPay ETF
NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.
Read more on NVDW →
